Lupus alpha Smaller German Champions C
Lupus alpha Smaller German Champions C
Lupus alpha Smaller German Champions primarily invests in a selection of actively managed MDAX and SDAX shares. It provides investors with exposure to German companies which are extremely successful internationally and have been selected carefully using fundamental analyses with the objective of participating in their market success across the globe.
- "Hidden gems" combined with robust, internationally well-positioned German mid-cap companies steeped in tradition
- Attractive risk-return profile
- Positive diversification into German and European large caps.
- Consistent bottom-up approach
- Attractive long-term equity investment
- First-class fund management
Lupus alpha has one of the largest and most experienced portfolio management teams in Europe for German small and mid caps. A large, focused team is a crucial factor for success in an active, fundamentally-based stock-picking process:
FOCUSED TEAM
... and one of the largest small & mid cap teams in Europe
LONGSTANDING EXPERIENCE
... in the team and an excellent track record since 2001
DETAILED COMPANY KNOWLEDGE
... based on around 1,500 direct and personal company contacts per year
LARGE INVESTMENT UNIVERSE
... with around 2,000 individual stocks – ideal for stock picking to achieve alpha
SDAX and MDAX shares – actively managed with a bottom-up strategy
The fund primarily invests in stocks from the MDAX and SDAX index. Internationally very well positioned companies - often world market leaders - are represented here. Due to lean company structures of most medium sized businesses, they are much more maneuverable in cyclical downturns than large companies. In order to filter out the most profitable stocks from this universe, the fund management relies primarily on personal discussions with the management and on-site visits to the company. The investment objective of the fund is to outperform the benchmark index (consisting of the 50% MDAX + 50% SDAX performance index) over the long term through targeted stock selection.
The fund's investment objective is to outperform the benchmark (a 50/50 split between the MDAX and SDAX Performance Index) over the long term using targeted stock-selection. The sector allocation of the benchmark index is only of secondary importance.
Experienced fund managers
Fund Manager Björn Glück has more than 15 years of experience managing small- and mid-cap strategies and has been working with Lupus alpha since 2005. Jonas Liegl, the experienced small- and mid-cap fund manager, has more than 10 years of experience in the analysis and portfolio management of European micro-, small- and mid-caps for large institutional mandates.
Performance (gross in EUR)¹:
| from | to | Lupus alpha Smaller German Champions C | 50% SDAX Performance Index : 50% MDAX Performance Index | |
|---|---|---|---|---|
| 1 month | 31.10.2024 | 29.11.2024 | 0.08 % | 0.73 % |
| 90 days | 30.08.2024 | 29.11.2024 | -3.77 % | -0.60 % |
| 1 year | 29.11.2023 | 29.11.2024 | -3.91 % | 1.34 % |
| 3 years | 29.11.2021 | 29.11.2024 | -23.74 % | -19.82 % |
| 5 years | 29.11.2019 | 29.11.2024 | 15.70 % | 3.86 % |
| this year | 29.12.2023 | 29.11.2024 | -7.80 % | -2.87 % |
| since inception | 08.01.2002 | 29.11.2024 | 873.96 % | 479.58 % |
| since inception p.a. | 08.01.2002 | 29.11.2024 | 10.45 % | 7.97 % |
| 12-month-timeframe (gross) | Lupus alpha Smaller German Champions C | 50% SDAX Performance Index : 50% MDAX Performance Index |
|---|---|---|
| 30.11.2023 - 30.11.2024 | -3.91 % | 1.34 % |
| 30.11.2022 - 30.11.2023 | 1.82 % | 4.05 % |
| 30.11.2021 - 30.11.2022 | -22.21 % | -24.01 % |
| 30.11.2020 - 30.11.2021 | 25.72 % | 16.78 % |
| 30.11.2019 - 30.11.2020 | 20.05 % | 10.12 % |
| 30.11.2018 - 30.11.2019 | 14.09 % | 15.56 % |
| 30.11.2017 - 30.11.2018 | -12.78 % | -12.12 % |
| 30.11.2016 - 30.11.2017 | 39.31 % | 30.23 % |
| 30.11.2015 - 30.11.2016 | -2.33 % | -1.64 % |
| 30.11.2014 - 30.11.2015 | 33.85 % | 27.53 % |
Key Statistics³:
| as of | Lupus alpha Smaller German Champions C | 50% SDAX Performance Index : 50% MDAX Performance Index | |
|---|---|---|---|
| Volatility p.a. | 29.11.2024 | 18.37 % | 18.64 % |
| Tracking Error | 29.11.2024 | 4.39 % | n.a. |
| Investment Quota | 29.11.2024 | 96.72 % | n.a. |
Top ten holdings as of 29/11/2024
| Delivery Hero AG |
| Fresenius Med. Care AG |
| Fuchs SE |
| GEA Group AG |
| Gerresheimer AG |
| IONOS Group SE |
| Knorr-Bremse AG |
| PUMA SE |
| Redcare Pharmacy NV |
| Talanx AG |
| Total number of assets: 67 |
| Total weight of top ten: 28.72 % |
Sector allocation as of 29/11/2024
Chances
- Participation in fundamental and technical events of individual stocks.
- You can benefit from the deep network that our fund managers foster with small- and mid-cap companies of our investment universe.
- The investment process enhances the security selection and ensures permanent monitoring of risks.
- You can benefit from information advantages that arise from the lower analyst coverage of small- and mid-cap companies.
- Promising upside potential of european small- and mid-cap stocks.
Risks
- Risk of price changes: Experience shows that equities are subject to sharp price fluctuations and thus the risk of price declines. These fluctuations are particulary impacted by the earnings development of the issuing company as well as sector trends and overall economic development.
- Concentration risk: If investment is concentrated on particular assets or markets, the fund becomes particularly heavily dependent on the performance of these assets or markets.
- Operational risk: The fund can become the victim of fraud, criminal acts or errors by company employees or external third parties. Finally, management of the fund can be negatively impacted by external event such as fires, natural disasters or similar.
- Liquidity risk: If securities are traded in a relatively narrow market segment, it can be difficult to resell them in situations where there is insufficient liquidity.
- Market risk: the performance of financial products depends on the development of the capital markets.
Current fund data as of 12/20/2024
Lupus alpha Smaller German Champions C WKN : 940640 | ISIN: LU0129233507 | |
|---|---|
Currency
| EUR |
Issue price
| 497,42 |
Redemption price
| 473,73 |
Fund volume
| 462,23 Mio. |
Launch date
| 08. janvier 2002 |
Minimum investment amount
| 500.000 |
Distribution frequency
| distribution |
Portfolio managers
| Björn Glück, Jonas Liegl |
Performance fee
| 12,5 % |
Administration fee
| 1,0 % |
Subscription fee
| up to 5 % |
Morningstar Rating
| ★★★★ |
Benchmark
| 50 % MDAX® + 50 % SDAX® |
Unit price determined
| daily |
Unit redemption possible
| daily |
Share class
| institutional |
Fund price publication
| www.fundinfo.com |
Current fund data as of 12/20/2024
Lupus alpha Smaller German Champions A WKN : 974564 | ISIN: LU0129233093 | |
|---|---|
Currency
| EUR |
Issue price
| 434,96 |
Redemption price
| 414,25 |
Fund volume
| 462,23 Mio. |
Launch date
| 03. août 2001 |
Distribution frequency
| distribution |
Portfolio managers
| Björn Glück, Jonas Liegl |
Performance fee
| 17,5 % |
Administration fee
| 1,5 % |
Subscription fee
| up to 5 % |
Morningstar Rating
| ★★★★ |
Benchmark
| 50 % MDAX® + 50 % SDAX® |
Unit price determined
| daily |
Unit redemption possible
| daily |
Share class
| retail |
Fund price publication
| www.fundinfo.com |
This fund information is provided for general information purposes. This information is not designed to replace the investor‘s own market research nor any other legal, tax or financial information or advice. The information presented does not constitute an invitation to buy or sell or investment advice. It does not contain all key information required to make important economic decisions and may differ from information and estimates provided by other sources or market participants. We accept no liability for the accuracy, completeness or topicality of this information. All statements are based on our assessment of the present legal and tax situation. All opinions reflect the current views of the portfolio manager and can be changed without prior notice. Full details of our funds and their licenses of distribution can be found in the relevant current sales prospectus and, where appropriate, Key Investor Information Document , supplemented by the latest audited annual report and/or half-year report. The relevant sales prospectus and Key Investor Information Documents prepared in German are the sole legally-binding basis for the purchase of funds managed by Lupus alpha Investment GmbH. You can obtain these documents free of charge from Lupus alpha Investment GmbH, P.O. Box 1112 62, 60047 Frankfurt am Main, Germany, upon request by calling +49 69 365058-7000, by e-mailing service@lupusalpha.de or via our website www.lupusalpha.de. If funds are licensed for distribution in Austria the respective sales prospectus, Key Investor Information Document and the latest audited annual report or half-year report are available from the Austrian paying and information agent UniCredit Bank Austria AG based in Rothschildplatz 1, 1020 Vienna, Austria. Fund units can be obtained from banks, savings banks and independent financial advisors.
Neither this fund information nor its contents or a copy thereof may be amended, reproduced or transmitted to third parties in any way without the prior written consent of Lupus alpha Investment GmbH. By accepting this document, you declare your consent to comply with the aforementioned provisions. Subject to change without notice.
Lupus alpha Investment GmbH
Speicherstraße 49–51
D-60327 Frankfurt am Main
- Source: Lupus alpha; gross performance (BVI method): The gross performance considers all costs incurred at Fund level (e. g. management fee) and assumes reinvestment of any distributions. Costs incurred at customer level such as sales charge and securities account costs are not included. Unless otherwise specified, all indicated performance data show the gross performance. Please note: Past performance is not a reliable indicator the future performance.
- Source: Lupus alpha; the net performance assumes a model calculation based on an invested amount of EUR 1,000, the maximum sales charge and a redemption charge (see master data). It does not include individual costs of the investor, such as a securities account fee. (To this effect, please refer to the price list of your securities account provider.) Please note: Past performance is not a reliable indicator for future performance.
- Volatility is the range of variation of a security price or index around its mean value over a fixed period of time. A security is regarded as volatile if its price fluctuates heavily. The tracking error describes the standard deviation (volatility) between the Fund's performance and the performance of the benchmark index. The higher the tracking error, the more the performance of the Fund deviates from the performance of the benchmark index. The investment ratio means the part of the Fund that is not invested in cash.
- The sales charge is the difference between the sales price and the unit value. The sales charge varies depending on the type of the Fund and the distribution channel and usually covers the advisory and distribution costs. The Distributor will demand the sales charge at its own discretion.
- The management fee is the fee for managing the Fund and taken from the Fund's assets; it is paid to Lupus alpha for the management and administration of the Fund.
- The performance fee is a performance-related remuneration depending on the performance or the achievement of specific objectives such as a better performance compared to a benchmark. The costs may also be levied if a pre-defined minimum performance has been achieved.
- Distributing Funds do not reinvest the generated income, they pay out the income to the investor.
- Morningstar Rating™ Total: © (2019) Morningstar Inc. All Rights Reserved. The information contained herein: 1. is intended for Morningstar and/or its content providers. 2. may not be reproduced or distributed; and 3. their accuracy, completeness or timeliness is not guaranteed. Neither Morningstar nor their content providers are responsible for any damages or losses arising from the use of this information. Ratings related to the previous month.